The Ledger

There are no recent headlines or clear fundamental catalysts explaining today's ~3.1% decline in CRM, making it difficult to assess whether this is a sustained move or a low-volume drift. The macro context (elevated 5Y inflation expectations) is more relevant to commodities and TIPS than to enterprise software, providing no directional signal for CRM specifically. With only 45 minutes remaining until the forced close cutoff, even if a thesis existed, limited time reduces the probability of meaningful continuation.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

LLY has moved up 2.55% today but there are no recent headlines or clear catalysts explaining the move, making it difficult to assess whether this is fundamentally driven or a technical/flow-based rally. The macro context (elevated 5-year inflation expectations) is not directly supportive of pharma/large-cap biotech continuation. With only 45 minutes remaining until the forced close cutoff, there is limited time for meaningful additional upside even if momentum persists, and late-day profit-taking risk is elevated after a ~$25 intraday gain.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.48
}

There are no recent headlines or identifiable catalysts explaining ORCL's -4.41% decline today, making it difficult to assess whether this is a fundamental repricing or a technical/liquidity-driven move. The macro context (elevated 5-year inflation expectations) is not directly bearish for ORCL as a tech/enterprise software name, offering no clear directional signal. With only 45 minutes remaining until the forced close cutoff, even if a thesis existed, there is limited time for meaningful continuation, and late-session mean-reversion is plausible in the absence of a clear catalyst.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

COST has made a solid 2.17% intraday move with no identifiable news catalyst or earnings event to anchor continuation — this raises the possibility of a gap-fill or mean-reversion into the close. The macro context highlights elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which is broadly neutral-to-negative for consumer discretionary/staples like Costco rather than a tailwind. With only 45 minutes remaining until the forced close cutoff, there is limited time for meaningful continuation even if the setup were stronger.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

UNH is up 2.44% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is simply mean-reverting noise. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to a managed care/health insurance name like UNH. With only 45 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and without a clear catalyst, the risk of intraday reversal or fade into the close is elevated.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

WMT is up 2.14% with no identifiable headline catalyst driving the move, making it difficult to assess whether this is sustainable momentum or a gap-fill/institutional repositioning event. The macro context (elevated 5Y inflation expectations at 1.9σ above trend) is not directly bullish for a consumer staples/retail name like WMT and offers no clear sector tailwind. With only 45 minutes remaining until the forced close cutoff, there is limited runway for meaningful continuation even if the thesis were clearer, and without a catalyst, mean-reversion risk is non-trivial.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the 2.53% move in NFLX today, making it difficult to assess whether this is momentum-driven or a low-conviction drift. The macro context references elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for growth/tech names like NFLX and could create mild headwinds. With only 45 minutes remaining until the forced close, there is limited time for meaningful continuation even if the setup were stronger.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

AMD is down 4.41% but recent headlines actually skew positive for AI/chip demand, with Wedbush reinforcing AI tailwinds — this creates a potential mean-reversion setup rather than a continuation catalyst. With only 45 minutes remaining until the forced close, there is limited time for the downtrend to extend meaningfully, and late-session dip-buying in high-profile AI names is common. The elevated 5Y inflation breakeven (2.62, ~1.9σ above trend) adds macro uncertainty but is not a direct chip-sector headwind, leaving the directional edge unclear.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear catalysts explaining the ~3.3% decline in AVGO, making it difficult to assess whether this is a fundamentally-driven move or noise/sector rotation. The macro context (elevated 5Y inflation expectations) is not directly relevant to semiconductor names like AVGO. With only 45 minutes remaining until the forced close, there is limited time for meaningful continuation even if a catalyst were present, and mean-reversion into the close is a common intraday pattern for large-cap tech names without confirmed news.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

KO has moved up 2.07% today with no identifiable headline catalyst to explain the move, suggesting this may be a gap or sector rotation rather than a news-driven momentum trade. The macro context highlights elevated inflation expectations (T5YIE 1.9σ above trend), which is modestly negative for consumer staples like KO as a defensive yield proxy relative to TIPS and commodities. With only 45 minutes remaining until the forced close, there is limited runway even if the setup were favorable, making continuation less actionable.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

ABBV is up 2.73% with no accompanying news headlines to explain the move, making it difficult to attribute the gain to a clear fundamental catalyst that would drive further continuation. The macro context (elevated 5-year inflation expectations) is not directly relevant to a large-cap pharma/biotech name like ABBV. With only 45 minutes remaining until the forced close, there is limited time for meaningful additional upside even if the move were catalyst-driven, and without a clear story the risk of mean reversion or profit-taking into the close is elevated.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.48
}

There are no recent headlines or clear catalysts explaining the -3.23% move in TSLA today, making it difficult to assess whether selling pressure has a fundamental driver that would sustain into the close. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not directly bearish for TSLA and does not provide a clear directional signal. With only 45 minutes remaining and no identifiable catalyst, mean-reversion or stabilization is roughly as likely as continuation, so confidence in a directional call is low.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

ABBV has moved up 2.84% with no identifiable news catalyst in the headlines, suggesting the move may be driven by sector rotation, options activity, or thin volume rather than a fundamental event. The macro context (elevated 5Y inflation expectations) is not directly supportive of a healthcare/pharma name like ABBV. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst, mean reversion or consolidation is equally plausible.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts to explain the -3.19% move in AVGO today, making it difficult to assess whether this is a sustained selling episode or a gap-down that may partially recover. The macro context (elevated 5Y inflation expectations) is not directly bearish for semiconductor names like AVGO. With only 60 minutes remaining and no identifiable catalyst supporting continuation, the risk/reward for a directional bet is unfavorable.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

COST has moved up ~2.1% with no identifiable catalyst from recent headlines, suggesting the move may be gap-related or driven by broader market sentiment rather than a specific fundamental driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not directly a tailwind for a consumer staples/warehouse retailer like Costco and could even pressure margins. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation, and without a clear catalyst the risk of mean reversion or consolidation is elevated.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the -3.28% decline in CRM today, making it difficult to assess whether this is a fundamental move or noise/sector rotation. The macro context (elevated 5Y inflation expectations) is more relevant to commodity-linked sectors than enterprise software, offering no directional signal for CRM. With only 60 minutes remaining and no identifiable catalyst, the probability of meaningful continuation is limited and the setup does not meet the threshold for a high-conviction trade.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

KO has moved up 2.03% with no identifiable news catalyst to explain the move, suggesting this may be a gap or broader market-driven lift rather than a stock-specific driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly favorable for a consumer staples/defensive name like KO as it implies rate pressure. With only 60 minutes remaining, there is limited runway for meaningful continuation, and without a clear fundamental catalyst the probability of sustained buying into the close is below threshold.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

LLY has moved up 2.54% today with no accompanying news catalysts or earnings events visible in the headlines, making it difficult to attribute the move to a durable fundamental driver. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is more relevant to Gold, Energy, and TIPS sectors, not large-cap pharma, providing no tailwind support. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst the move risks fading or consolidating into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear fundamental catalysts to explain the -4.56% move in ORCL today, making it difficult to assess whether selling pressure has a narrative driver that would sustain it into the close. The macro context (elevated 5-year inflation expectations) is not directly bearish for a large-cap tech/software name like Oracle. With only 60 minutes remaining and no identifiable catalyst, the move may reflect morning institutional selling or thin liquidity rather than a sustained trend, suggesting limited additional downside conviction.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or identifiable catalysts explaining the 2.28% move in NFLX, making it difficult to assess whether this is driven by sustained buying interest or a thin-volume spike. The macro context (elevated 5-year inflation expectations) is not particularly constructive for a growth/technology name like Netflix, as higher real rates tend to pressure high-multiple equities. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation even if the setup were more compelling.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or catalysts explaining the ~3.5% decline in TSLA today, making it difficult to assess whether this is a fundamental move or noise/technical selling. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA specifically. With only 60 minutes remaining until the forced close, there is limited time for a meaningful continuation, and without a clear catalyst, mean-reversion or stabilization into the close is equally plausible.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

AMD is down 4% but the macro news environment is broadly constructive for AI/chip names — Wedbush's positive AI demand commentary and Intel's massive intraday gain suggest sector sentiment is not uniformly negative, creating reversal risk. The drop may reflect a gap or early-session pressure rather than a sustained catalyst specific to AMD, as no AMD-specific negative news appears in the headlines. With only 60 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and mean-reversion into the close is common in the absence of a clear ticker-specific catalyst.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear catalysts explaining CRM's ~2.92% decline today, making it difficult to assess whether selling pressure will persist into the close. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than to a software name like CRM, providing no directional edge. With 74 minutes remaining and no identifiable news-driven catalyst, the move could reflect broad market noise or sector rotation, and a partial mean-reversion into the close is equally plausible.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear fundamental catalysts to explain the -3.43% decline in TSLA today, making it difficult to assess whether this is a sustained move or a mean-reversion opportunity. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is not directly negative for TSLA in the short term and does not provide a strong directional signal. With 74 minutes remaining and no identifiable catalyst, the probability of continuation versus reversal is roughly even, warranting an uncertain stance.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

COST is up ~2% with 74 minutes remaining but there are no recent headlines or identifiable catalysts driving the move, making it difficult to assess whether this reflects fundamental buying or noise. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not a direct tailwind for consumer staples/warehouse retail like Costco. Without a clear catalyst and given that a 2% intraday move in a large-cap like COST without news often reverts partially into the close, continuation is uncertain.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

AMD is down ~4% today, but the macro backdrop from recent headlines is constructive for AI chip demand, with Wedbush reinforcing AI strength across chips and cloud — this could provide buying pressure into the close and limit further downside. The elevated 5-year inflation breakeven (1.9σ above trend) adds some macro uncertainty, but is not a direct chip sector headwind. With 74 minutes remaining, there is meaningful time for a partial recovery, and the lack of a clear company-specific negative catalyst suggests the move may be overdone rather than a sustained directional trend.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

LLY is up 2.42% with no identifiable news catalyst driving the move, making it difficult to assess whether momentum will sustain into the close. The macro context around elevated 5-year inflation expectations is not directly relevant to a large-cap pharma name like LLY. With 74 minutes remaining, there is some time for continuation, but absent a clear fundamental catalyst, the move could easily fade or consolidate near current levels.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or identifiable catalysts to explain the 2.31% intraday move in NFLX, making it difficult to assess whether the move is driven by fundamental news or is simply noise/thin-volume drift. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for growth/tech names like NFLX and could even be a mild headwind. With 74 minutes remaining and no clear catalyst supporting continuation, the move has a reasonable chance of mean-reverting or stalling into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the -3.05% move in AVGO today, making it difficult to assess whether this is a fundamental shift or a technical/macro-driven dip. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is a broader headwind for growth/tech names like AVGO but is not a direct catalyst. With 74 minutes remaining, there is limited time for further meaningful downside continuation without a fresh catalyst, and mean-reversion pressure is plausible in the absence of news-driven selling.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

ABBV has moved up 3.16% today with no identifiable headline catalyst in the last 24 hours, making it difficult to assess whether this move has fundamental support or is driven by technical flows or sector rotation. The macro context flags elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a clear tailwind for healthcare/pharma names like ABBV. With 74 minutes remaining, there is insufficient catalyst clarity to confidently expect continuation, and large gap-up moves without news often see partial mean reversion into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or identifiable catalysts explaining the ~4.5% decline in ORCL today, making it difficult to assess whether this is a fundamental driver or technical/flow-driven move. The macro context (elevated 5-year inflation expectations) is most relevant to commodities and TIPS, not directly to an enterprise software name like Oracle. With 74 minutes remaining and no clear news catalyst, mean-reversion pressure is plausible, but without understanding the source of the move, conviction in either direction is low.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.38
}

ABBV has moved up ~2.87% with no identifiable news catalyst in the last 24 hours, suggesting the move may be gap-driven or sector-rotation-related rather than fundamentally supported. The macro context (elevated 5-year inflation expectations) is not directly relevant to a large-cap pharma name like ABBV. With 90 minutes remaining and no clear continuation catalyst, mean reversion or consolidation near current levels is equally plausible as further upside.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the -3.66% intraday drop in TSLA, making it difficult to assess whether this is a sustained trend or a temporary dip. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA and does not provide a strong directional signal. With 90 minutes remaining and no identifiable news driver, the move could mean-revert into the close as buyers step in at a discount, warranting an uncertain stance rather than a continuation bet.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

AMD is down ~4.71% but the macro headline environment is actually constructive for AI/chip names — Wedbush reinforced AI demand strength and Intel saw a massive move higher, suggesting sector rotation rather than broad chip weakness may be at play. The elevated 5-year inflation expectations (2.62, +1.9σ) are not a direct AMD catalyst and the positive sector backdrop creates meaningful mean-reversion pressure. With 90 minutes remaining and no clear company-specific negative catalyst visible in the headlines, the risk/reward for continuation is roughly balanced, leaning slightly toward recovery rather than further downside.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear catalysts explaining the ~3.54% decline in AVGO today, making it difficult to determine whether this is a sustained directional move or a gap/spike that may partially reverse. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO, offering no strong confirming signal for continuation. With 90 minutes remaining and no identifiable news driver, mean-reversion pressure is plausible, and the risk/reward for a continuation trade is unclear.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or identifiable catalysts to explain the 2.22% move in NFLX today, making it difficult to assess whether this is a sustained trend or a low-volume intraday spike. The macro context (elevated 5-year inflation expectations) does not particularly favor consumer discretionary/streaming names and provides no directional tailwind. With 90 minutes remaining there is modest time for continuation, but without a clear fundamental driver the probability of sustained upside into the close is not compelling enough to warrant a high-confidence directional bet.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the ~4.84% decline in ORCL, which makes it difficult to assess whether this is a fundamental move or noise/thin-volume selling. The macro context around elevated 5-year inflation expectations is more relevant to commodities and TIPS than to large-cap tech/software like ORCL. With 90 minutes remaining and no supporting narrative, mean-reversion is plausible, but without a clear catalyst for either continuation or reversal, the most prudent call is uncertain.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

COST has moved up 2.08% today with no identifiable catalyst from recent headlines, making it difficult to assess whether this is a sustained move or a gap/spike with limited follow-through. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for consumer staples/warehouse retail like Costco. With 90 minutes remaining, there is some time for continuation, but without a clear fundamental driver, mean reversion or consolidation near current levels is equally plausible.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear fundamental catalysts driving CRM's -2.78% decline today, making it difficult to assess whether the move reflects genuine selling pressure or noise. The macro context (elevated 5Y inflation expectations) is more relevant to commodities and TIPS sectors than enterprise software, providing no directional edge for CRM. With 90 minutes remaining and no catalyst to anchor a view, the move could easily mean-revert into the close, so conviction is low.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

LLY is up 2.41% with no identifiable catalyst from recent headlines to explain or sustain the move, making it difficult to assign directional conviction. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to large-cap pharma and provides no sector tailwind. With 90 minutes remaining and no clear fundamental driver, the move may represent profit-taking risk or a gap-fill scenario rather than a sustained trend into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

Netflix's Q1 2026 financials are robust — $10.5B revenue, $2.9B net income, and $9B cash on hand reflect a fundamentally strong business. However, the 19.6% drop from the 30-day high appears to carry meaningful idiosyncratic headwinds: a Texas lawsuit alleging illegal data collection on children is a material regulatory risk that could attract further state-level actions, and the broader macro environment (elevated 5Y inflation breakevens, weak QQQ/IWM today) is not supportive of a near-term technical recovery. The $87.61 price is well below recent highs with no clear near-term catalyst to reverse the slide.

{
  "sound": true,
  "reason": "low_conviction",
  "probability": 0.38
}

{
  "availableCash": 95291.98996792654,
  "costPerContract": 4950.983662293439,
  "desiredNotional": 1000.5815607435211
}

{
  "availableCash": 95291.98996792654,
  "costPerContract": 2141.172364389814,
  "desiredNotional": 1000.5815607435211
}

{
  "availableCash": 95291.98996792654,
  "costPerContract": 1492.0867714971023,
  "desiredNotional": 1000.5815607435211
}

Netflix's most recent 10-Q shows strong fundamentals: $10.5B in quarterly revenue, $2.89B net income, $2.79B operating cash flow, and $9B in cash — no signs of financial deterioration. However, the 19.6% drop from the 30-day high appears to carry idiosyncratic stress (Texas lawsuit over data/privacy practices, rising regulatory scrutiny, price hike concerns) on top of a risk-off macro backdrop where QQQ is down 1.73% and IWM down 1.59%, and elevated 5-year inflation breakevens (T5YIE at 1.9σ above trend) compress growth multiples. The combination of genuine legal headline risk and a broad tech sell-off makes a full rebound to $108.95 within 90 days uncertain.

{
  "sound": true,
  "reason": "low_conviction",
  "probability": 0.41
}

Netflix's most recent 10-Q shows strong fundamentals: $10.5B in quarterly revenue, $2.9B net income, and $9B in cash, with positive operating cash flow — no signs of financial deterioration. The 19.6% pullback appears driven by macro headwinds (elevated 5-year inflation expectations at 1.9σ above trend pressuring growth multiples) and headline noise from a Texas lawsuit over data practices, rather than a fundamental business breakdown. However, the Texas lawsuit introduces real legal/regulatory overhang, and the current price of $87.61 against a $108.95 30-day high implies a meaningful re-rating that may not fully reverse within 90 days given the macro environment.

{
  "sound": true,
  "reason": "low_conviction",
  "probability": 0.41
}

The 2.06% move in WMT lacks a clear intraday catalyst visible in the headlines; the only recent coverage questions whether WMT is overvalued after strong gains, which is a mild headwind to further buying pressure. With 105 minutes remaining there is time for continuation, but elevated inflation expectations (T5YIE at 1.9σ above trend) could pressure consumer discretionary/staples sentiment and invite profit-taking in a name that has already run. Without a fresh fundamental catalyst such as an earnings beat or analyst upgrade, the move looks more like a gap or sector drift than a high-conviction continuation setup.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear fundamental catalysts driving the -2.72% move in CRM today, making it difficult to assess whether selling pressure has a thesis behind it or is noise/broad market sympathy. The macro context (elevated 5Y breakeven inflation) is more relevant to commodities and TIPS than enterprise software, providing no direct headwind or tailwind signal for CRM. With 105 minutes remaining, mean-reversion is plausible in the absence of a clear catalyst, so continuation is not favored with high confidence.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear catalysts to explain the ~3.74% decline in AVGO today, making it difficult to assess whether this is a fundamental driver or a sympathy move with broader market dynamics. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO, and without news-driven conviction, mean reversion into the close is plausible. With 105 minutes remaining and no identifiable catalyst, the move could partially retrace, warranting an uncertain stance rather than a continuation bet.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

ABBV is up 3.19% with no identifiable news catalyst or earnings event driving the move, making it difficult to assess whether this is a sustainable directional trend or a gap/spike that may fade. The macro context (elevated 5-year inflation expectations) is not directly relevant to ABBV as a healthcare/pharma name. With 105 minutes remaining and no clear fundamental catalyst, mean-reversion pressure after a ~3% intraday move is a real risk, and the lack of headlines leaves the driver ambiguous.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

NFLX is up 2.79% with no recent headline catalyst visible, suggesting the move may be driven by broader market momentum or sector rotation rather than a company-specific event. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for growth/tech names like NFLX and could create headwinds. With 105 minutes remaining and no clear fundamental catalyst to anchor the move, mean reversion or consolidation is as likely as continuation.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the ~4.85% decline in ORCL today, making it difficult to assess whether selling pressure is fundamentally driven or represents a gap/flush that may stabilize. The macro context (elevated 5-year inflation expectations) is not directly bearish for a large-cap tech/cloud name like Oracle in the near term. With 105 minutes remaining, there is meaningful time for either a partial recovery or continued drift, but without a clear catalyst the setup does not meet the threshold for a high-conviction continuation trade.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

LLY is up 2.60% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is noise/technical in nature. The macro context (elevated 5Y inflation expectations) is not directly relevant to a large-cap pharmaceutical like LLY, offering no sector tailwind. With 105 minutes remaining and no clear news-driven catalyst, the probability of sustained continuation into the close is roughly coin-flip, and a cautious uncertain stance is warranted.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There is no clear fundamental catalyst in the recent headlines explaining today's -4.01% decline in TSLA beyond general market activity, making it difficult to assign high conviction to continuation. The macro context highlights elevated inflation expectations (T5YIE at 2.62, 1.9σ above trend), which is more directly reactive to Gold/Energy/TIPS sectors than to TSLA specifically. With 105 minutes remaining, there is meaningful time for either a bounce or further selling, but absent a clear news-driven catalyst, mean reversion intraday is equally plausible, warranting an uncertain stance.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The headline evidence is broadly constructive for AI/chip names (Wedbush noting strong AI demand), which creates a headwind against continued selling pressure on AMD specifically. The -4.83% decline lacks a clear negative catalyst in the recent headlines, suggesting this may be symptomatic of broader sector rotation or profit-taking rather than a sustained directional move. With 105 minutes remaining and a macro backdrop that is mildly inflationary (elevated 5Y breakevens) but not outright bearish for semis, a mean-reversion bounce into the close is at least as likely as continuation of the selloff.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

COST is up ~2.08% with no identifiable news catalyst in the last 24 hours, making it difficult to attribute the move to a specific fundamental driver that would support continuation. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not a direct tailwind for a consumer staples/warehouse retailer like Costco. With 105 minutes remaining and no clear catalyst, the move looks more like a gap or broad-market lift than a conviction-driven rally, suggesting mean-reversion or consolidation is as likely as continuation.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

COST is up 2.30% with no visible news catalyst driving the move, making it difficult to assess whether this is fundamental buying or a gap that may fade. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for a consumer staples/warehouse retailer like Costco and could weigh on discretionary spending sentiment. With 135 minutes remaining and no confirming catalyst, the risk of mean reversion is meaningful, warranting an uncertain stance.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The 2.47% move in WMT lacks a clear intraday catalyst — the only recent headline questions whether the stock is overvalued after recent gains, which is a mildly bearish narrative that could cap further upside. With 135 minutes remaining there is time for movement, but absent a strong fundamental catalyst like earnings or a sector tailwind, large gap-up moves in defensive consumer staples names like WMT tend to consolidate or fade intraday rather than continue. The elevated inflation expectations (T5YIE at 1.9σ above trend) are not a direct tailwind for WMT and could weigh on consumer discretionary sentiment, adding further uncertainty to continuation.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

JNJ has moved up 2.38% with no identifiable headline catalyst driving the move, suggesting this could be a gap or sector rotation rather than a sustained fundamental shift. The macro context (elevated 5Y inflation breakevens at 1.9σ above trend) favors commodity and inflation-sensitive sectors like Energy and Gold, not healthcare defensives like JNJ — this could even act as a mild headwind for continuation. With 135 minutes remaining and no clear catalyst to sustain momentum, mean-reversion risk is elevated and confidence in continuation is low.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

AVGO is down ~4% with no recent headlines to explain the move, making it difficult to identify a clear catalyst supporting continuation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors and doesn't provide a clear directional signal for AVGO specifically. With 135 minutes remaining and no fundamental news anchor, mean reversion is plausible, but the magnitude of the move and lack of context create too much uncertainty to confidently call direction.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

The -4.15% drop lacks a clear negative catalyst in recent headlines; in fact, the Musk/Cook/Trump/Xi summit news is potentially a mild positive for TSLA given trade-war de-escalation implications for supply chains. Elevated 5Y inflation expectations (2.62, +1.9σ) create a macro headwind for growth stocks like TSLA, but this is not a fresh catalyst specific to today. With 135 minutes remaining, there is enough time for a partial mean-reversion bounce off the intraday lows rather than further continuation lower.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

NFLX is up 3.29% with no accompanying headlines or identifiable catalyst, suggesting this may be a gap or thin-volume move rather than a fundamentally-driven rally. The macro context points to elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a tailwind for high-multiple growth names like NFLX. With 135 minutes remaining there is time for movement, but without a clear catalyst to sustain buying pressure, mean-reversion is equally plausible.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

LLY is up ~3% intraday but there are no recent headlines or identifiable catalysts explaining the move, making it difficult to distinguish a sustained trend from a gap or thin-volume spike. The macro context (elevated 5Y inflation expectations) does not directly favor pharmaceutical/biotech names like LLY. With 135 minutes remaining, there is time for continuation, but without a clear news-driven catalyst, mean-reversion risk is meaningful and confidence in directional continuation is limited.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

ABBV has made a strong 3.62% move with 135 minutes remaining, but there are no identifiable catalysts in recent headlines to explain or sustain the move, suggesting it may be a gap or block-driven event rather than a news-driven continuation. The macro context (elevated 5-year inflation expectations) is not directly supportive of large-cap pharma like ABBV, which is not a typical beneficiary of inflation-reactive sectors. Without a clear fundamental driver, mean-reversion or consolidation into the close is at least as likely as continuation, warranting an uncertain stance.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

UNH is up 2.61% with no identifiable news catalyst in the headlines, suggesting the move may be a gap or algorithmic/sector rotation trade rather than a fundamentally driven continuation. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for managed healthcare names and provides no supporting narrative. With 135 minutes remaining there is time for continuation, but without a clear catalyst and given UNH's recent volatility history in the healthcare sector, the risk of mean reversion or fading into the close is material.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or company-specific catalysts to explain CRM's ~2.9% decline, making it difficult to assess whether the move reflects fundamental selling pressure or a broader market rotation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than to a SaaS name like CRM, providing no directional edge. With 135 minutes remaining and no clear catalyst, mean-reversion is as plausible as continuation, warranting an uncertain stance.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

The 3.21% intraday move in NFLX lacks an identifiable catalyst, as there are no recent headlines to explain the surge, raising the possibility this is a gap or volume spike without fundamental backing. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly supportive for high-multiple growth names like NFLX. With 150 minutes remaining, there is time for the move to either extend or mean-revert, but the absence of a clear news catalyst makes continuation uncertain and reduces conviction for a long-continuation trade.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or identifiable catalysts driving the ~3% decline in CRM today, making it difficult to assess whether selling pressure has a fundamental basis or is simply noise/sector rotation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than enterprise software, providing no clear directional signal for CRM. With 150 minutes remaining and no catalyst to sustain directional momentum, mean reversion is roughly as likely as continuation, warranting an uncertain stance.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

LLY's 2.75% move lacks a clear company-specific catalyst in the available headlines, with the only recent news referencing AMD and growth stocks broadly. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally a headwind for high-multiple growth/pharma names like LLY. With 150 minutes remaining there is time for continuation, but without a confirmed fundamental catalyst the move may be mean-reverting or sector-driven noise.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The -2.07% move in AMZN lacks a clear negative catalyst — recent headlines are broadly positive for big tech, highlighting strong AI demand and robust corporate profits, which would typically support AMZN's cloud/AWS segment. The macro context shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which could weigh on growth equities, but this is not an acute single-day catalyst for AMZN specifically. With 150 minutes remaining, there is enough time for a partial mean-reversion as institutional buyers may step in given the positive sector narrative, making the downside continuation uncertain.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

JNJ has moved up 2.23% today with no identifiable news catalyst visible in recent headlines, suggesting the move may be gap-driven or momentum-based rather than fundamentally supported. The macro context (elevated 5-year inflation expectations) is not particularly favorable for healthcare/defensive names like JNJ, which are not among the sectors typically reactive to T5YIE spikes. With 150 minutes remaining, there is time for either continuation or mean reversion, but the absence of a clear catalyst and the defensive nature of the stock suggest the move may fade or stall rather than extend meaningfully into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

UNH is up 2.25% but there are no UNH-specific headlines or catalysts visible in the evidence to explain or support continuation of this move — the only headline references AMD and unrelated growth stocks. The macro context (elevated 5Y inflation expectations) is mildly negative for healthcare/managed care names as it pressures discount rates and cost assumptions, not a tailwind. With 150 minutes remaining there is time for a move, but without a clear fundamental catalyst driving this specific ticker, the rally looks more like a gap or sector rotation bounce that may fade rather than accelerate into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

There are no recent headlines or clear catalysts explaining the ~4% intraday decline in AVGO, making it difficult to assess whether the move is fundamentally driven or a transient dislocation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductor names like AVGO, and without a news catalyst, large intraday gaps often see partial mean reversion into the close. With 150 minutes remaining, there is sufficient time for either continuation or reversal, but the absence of a clear driver argues against high-conviction continuation.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

ABBV is up 3.64% with no identifiable catalyst in recent headlines, suggesting this may be a gap-driven move without fresh fundamental support to sustain momentum into the close. The macro context (elevated 5Y inflation expectations) does not specifically benefit healthcare/pharma names like ABBV. With 150 minutes remaining, there is time for the move to extend, but absent a clear news catalyst and given the tendency for large gap-up moves without catalysts to partially fade mid-session, continuation is uncertain.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

The -4.31% move lacks a clear single negative catalyst; headlines are mixed with Musk joining a Trump-Xi summit (potentially positive for trade/EV) and a Robotaxi rollout story testing optimism rather than confirming a miss. With 150 minutes remaining, there is meaningful time for a partial recovery, especially if the summit headline drives sentiment reversal. Elevated 5-year inflation expectations (2.62, 1.9σ above trend) create macro headwinds broadly but are not TSLA-specific, and the absence of a definitive negative catalyst suggests the move may stall or partially retrace rather than continue lower into the close.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

COST is up 2.48% with no accompanying headlines or identifiable catalyst visible in today's session, making it difficult to attribute the move to a sustained fundamental driver versus a gap or thin-volume spike. The macro context (elevated 5-year inflation breakevens at 1.9σ above trend) is not a direct tailwind for consumer staples/warehouse retail like Costco and could even pressure margins if sustained. With 150 minutes remaining there is time for further movement, but without a clear catalyst the probability of meaningful continuation is insufficient to warrant a directional trade.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The 2.57% gap up in WMT lacks a clear same-day catalyst visible in the headlines — the most recent news questions whether WMT is overvalued after recent gains, which is a mild headwind to continuation. With 150 minutes remaining there is time for movement, but without a fresh earnings beat or sector-specific catalyst the move looks more like a broad market lift (potentially tied to macro risk-on sentiment) rather than a stock-specific driver. The elevated 5Y inflation breakeven (2.62, 1.9σ above trend) is modestly supportive of consumer staples defensively but not a strong directional catalyst for WMT specifically into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

JNJ has moved up 2.57% with no identifiable news catalyst or earnings event visible in recent headlines, suggesting this may be a gap-up or sector rotation move rather than a fundamentally-driven continuation. The macro context (elevated 5Y inflation expectations) is more relevant to Gold, Energy, and TIPS sectors than to healthcare/consumer staples like JNJ, providing no tailwind support. With 165 minutes remaining, there is time for movement, but without a clear catalyst and the risk of mean reversion on a news-vacuum gap, the probability of continuation is below threshold.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

COST is up 2.52% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is a momentum/gap-fill event. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is modestly supportive of consumer staples/warehouse retail like Costco as a defensive name, but this is not a direct catalyst. With 165 minutes remaining and no clear news driver, the risk of mean reversion is meaningful, warranting an uncertain stance rather than a high-confidence continuation call.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The ~5% intraday decline lacks a clear single negative catalyst — headlines are mixed, with Musk joining a high-profile Trump-Xi summit (potentially positive) and robotaxi/EV growth news that is sentiment-neutral to slightly positive. The macro context of elevated 5Y inflation breakevens (T5YIE at 1.9σ above trend) creates a modest headwind for high-multiple growth names like TSLA, but is not a direct trigger. With 165 minutes remaining, there is time for a partial mean-reversion bounce, especially given the absence of a decisive bearish catalyst and the possibility that the summit news provides a late-session lift.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

WMT's 2.63% gap up lacks a clear intraday catalyst in the recent headlines — no earnings release, guidance update, or sector-specific news driving the move, which raises the possibility this is a gap-and-fade scenario. The macro backdrop of elevated 5-year inflation expectations (2.62, ~1.9σ above trend) is a mild headwind for consumer discretionary/staples multiples, and one headline explicitly questions whether WMT is overvalued after recent gains. With 165 minutes remaining there is time for continuation, but without a strong fundamental catalyst the risk of mean reversion or consolidation near the day's highs is meaningful.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

AMZN is down ~2.23% intraday but the news flow is broadly positive for big tech, with Wedbush highlighting strong AI demand across cloud and software — sectors where AMZN (AWS) is a direct beneficiary. This creates a potential reversal setup rather than continuation of the decline, especially with 165 minutes remaining which gives ample time for a recovery. The macro backdrop of elevated 5-year inflation expectations (2.62, nearly 2σ above trend) adds modest headwind to growth/tech names, but is not a strong enough catalyst to confidently sustain the sell-off into the close.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

With no recent headlines or clear fundamental catalyst driving CRM's -2.61% decline today, the move lacks an identifiable narrative that would support high-confidence continuation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities sectors like Gold and Energy than to enterprise software names like CRM, providing no directional edge. With 165 minutes remaining there is still meaningful time for mean reversion, and without a catalyst anchoring sellers, a partial recovery into the close is at least as likely as further downside.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

AVGO is down 4.55% with no recent headlines to explain the move, making it difficult to identify a clear catalyst for continuation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO. With 165 minutes remaining, there is meaningful time for a partial rebound or stabilization, especially absent a fundamental driver for the selloff.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

ABBV is up 4% intraday with no accompanying headlines or identifiable catalyst visible in the data, suggesting this may be a gap or spike move without clear fundamental support for continuation. The macro context (elevated 5-year inflation expectations) is not directly relevant to a healthcare/pharma name like ABBV. With 165 minutes remaining there is time for continuation, but absent a clear catalyst, mean-reversion or consolidation is equally plausible, keeping conviction low.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

PEP has moved up ~2.08% with no identifiable catalyst in recent headlines, suggesting the move may be driven by broader market sentiment or a gap rather than a specific fundamental driver. The macro context (elevated 5Y inflation breakevens) is not particularly bullish for a defensive consumer staples name like PEP, which could face margin pressure concerns. With 165 minutes remaining and no clear news catalyst, mean reversion or consolidation near current levels is as plausible as continuation.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

The 3.78% intraday gain lacks a clearly visible positive catalyst — the only recent headline is a Texas lawsuit over data collection, which is a mild negative overhang that could weigh on sentiment as the session progresses. With 165 minutes remaining there is time for either continuation or reversal, but the absence of a confirmed bullish driver (no earnings beat, no upgrade, no sector tailwind) makes the move look potentially exhausted or technically driven. Elevated 5-year inflation expectations (2.62, ~1.9σ above trend) also create a macro headwind for high-multiple growth names like NFLX, further undermining conviction in upside continuation.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

LLY's 2.78% intraday gain lacks a clear stock-specific catalyst in the available headlines, which focus on AMD and unrelated growth stocks. The macro context flags elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally neutral-to-negative for high-multiple pharma names like LLY. With 165 minutes remaining there is time for the move to extend, but without a confirmed fundamental driver the gain could represent profit-taking territory or a broader market lift that may fade into the close.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.48
}

The 4.29% move up in NFLX lacks a clearly identifiable positive catalyst in the headlines — in fact, the most recent news is mildly negative (Texas lawsuit over data collection). With 180 minutes remaining, there is time for movement, but without a clear fundamental driver (earnings beat, upgrade, or sector tailwind), the initial gap may fade or consolidate rather than continue. The elevated inflation expectations macro environment (T5YIE at 1.9σ above trend) does not directly support growth/tech names like NFLX, adding a modest headwind to further upside.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

PEP has moved up ~2.07% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume drift rather than a news-driven momentum move. The macro context (elevated 5-year inflation expectations) is not directly favorable for a defensive consumer staples name like PEP, as rising inflation breakevens can pressure valuation multiples on low-growth dividend payers. With 180 minutes remaining there is time for mean reversion, and without a clear fundamental catalyst supporting continuation, the probability of further upside into the close is below the threshold for a high-conviction trade.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

WMT has already moved +2.43% today without a clear fresh catalyst — no earnings release, no major company-specific news driving the move, and the only recent headline questions whether the stock is overvalued after recent gains. With 3 hours remaining, there is time for continuation, but the absence of a identifiable catalyst suggests this may be a gap or sympathy move tied to broader market strength (Dow firm) rather than a durable intraday trend. Elevated 5-year inflation expectations (T5YIE at 1.9σ above trend) could modestly support consumer staples as an inflation-resistant sector, but this macro factor is not strong enough alone to justify a high-conviction continuation call.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

The -4.50% drop in AVGO lacks a clear direct catalyst in today's headlines; the Micron memory chip shortage news is net positive for semiconductors and could attract dip buyers into AVGO as a related AI/semiconductor name. The macro context shows elevated 5-year inflation expectations (2.62, +1.9σ), which is not a direct headwind for semiconductor equities. With 180 minutes remaining and no specific negative catalyst identified for AVGO, a partial mean-reversion or stabilization is plausible, making continuation of the downside move uncertain.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

There are no recent headlines or clear catalysts driving CRM's -2.37% decline today, making it difficult to assess whether selling pressure will persist into the close. The macro context (elevated 5-year inflation expectations) is most relevant to commodities and TIPS sectors, not directly to enterprise software like CRM. With 180 minutes remaining and no identifiable news catalyst, the move could reflect broad market noise or sector rotation, but lacks the fundamental support needed to assign high continuation probability.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

LLY has moved up 2.75% today but there is no direct LLY-specific catalyst visible in the provided headlines — the AMD/growth stock headline is not a meaningful driver for a large-cap pharma/biotech name. The macro context shows elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally a headwind for high-multiple growth stocks like LLY rather than a tailwind. With 180 minutes remaining, there is time for movement, but without a clear fundamental catalyst supporting continuation, mean reversion or consolidation is equally plausible.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.45
}

ABBV has moved up 3.40% today with no accompanying news catalysts visible, suggesting this could be a gap or technical move without a clear fundamental driver sustaining it. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS sectors than healthcare/pharma, providing no directional tailwind. With 180 minutes remaining there is time for movement, but absent a catalyst and with a sizable move already priced in, mean reversion risk is meaningful.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

The -4.90% decline in TSLA today lacks a clear single catalyst driving sustained selling pressure — headlines are mixed, with a Musk/Trump/Xi summit appearance potentially a mild positive and the robotaxi rollout story neutral-to-positive longer term. With 180 minutes remaining, there is ample time for either continuation or mean reversion, but elevated inflation expectations (T5YIE at 1.9σ above trend) create a risk-off macro backdrop that could weigh on high-beta growth names like TSLA. Given the ambiguous news flow and no definitive bearish catalyst confirmed, a full continuation into the close is not high-conviction, making this setup uncertain rather than a clear directional trade.

{
  "move_direction": "down",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}

JNJ has moved up 2.49% with no identifiable catalyst from recent headlines, suggesting this may be a gap or technical move rather than news-driven momentum. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly supportive of defensive healthcare names like JNJ. With 180 minutes remaining and no clear fundamental driver, the risk of mean reversion or consolidation is elevated, making continuation uncertain.

{
  "move_direction": "up",
  "direction_match": false,
  "claude_direction": "uncertain",
  "continuation_probability": 0.42
}